Type 2 & other diabetes

Maximum stress hyperglycemia ratio within the first 24 h of admission predicts mortality during and after the acute phase of acute coronary syndrome in patients with and without diabetes: A retrospective cohort study from the MIMIC-IV database

Diabetes Res Clin PractPublished Retrospective cohort study

Authors' conclusion

The maximum SHR was significantly associated with mortality in patients with ACS hospitalized in the ICU. However, caution is warranted if it is used for predicting mortality after 30 days in patients with diabetes.

Study context

Population
Patients with acute coronary syndrome (ACS) hospitalised in the intensive care unit (ICU), with and without diabetes, MIMIC-IV database
Participants
2,668 patients
Exposure
Maximum vs first stress hyperglycemia ratio for predicting mortality
Outcome
In-hospital and 1-year mortality
Methodological detailsMIMIC-IV database, landmark analysis at 30 days
  • MIMIC-IV database
  • Landmark analysis at 30 days

Main finding

As reported in the abstract

Mortality

In-hospital mortality

4.7 %

1-year mortality

13.2 %

Observational data: associations, not effects.

Further findings

Maximum stress hyperglycemia ratio (SHR) and mortality within 30 days (landmark analysis)

Maximum SHR was a risk factor for mortality within 30 days regardless of diabetes
  • Landmark analysis

Maximum SHR and mortality after 30 days, patients with diabetes

No longer associated with mortality after adjustment; HR per 1-point increment
1.237 (95 % CI 0.854-1.790)
  • Landmark analysis
  • Adjusted

Original publication

Maximum stress hyperglycemia ratio within the first 24 h of admission predicts mortality during and after the acute phase of acute coronary syndrome in patients with and without diabetes: A retrospective cohort study from the MIMIC-IV database. Diabetes Res Clin Pract. Published 1 February 2024. doi:10.1016/j.diabres.2024.111122

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.